Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 5
Submit an article Journal homepage
695
Views
13
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib

Lotta OhmDepartment of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
,
Adam LundqvistThe Swedish Institute of Health Economics, Lund, Sweden
,
Paul DickmanDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
,
Martin HöglundUnit of Hematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
,
Ulf PerssonThe Swedish Institute of Health Economics, Lund, Sweden;Lund Institute of Economic Research, School of Economics and Management, Lund University, Lund, Sweden
,
Leif StenkeDepartment of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
,
Katarina Steen CarlssonThe Swedish Institute of Health Economics, Lund, Sweden
&
Magnus BjörkholmDepartment of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
 show all
Pages 1385-1391 | Received 05 Apr 2014, Accepted 03 Aug 2014, Published online: 21 Oct 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Monia Marchetti. (2017) Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. Expert Review of Pharmacoeconomics & Outcomes Research 17:5, pages 469-480.
Read now
David Gómez-Almaguer, Olga G. Cantú-Rodríguez, Cesar H. Gutiérrez-Aguirre & Guillermo J. Ruiz-Argüelles. (2016) The treatment of CML at an environment with limited resources. Hematology 21:10, pages 576-582.
Read now

Articles from other publishers (11)

Martin Höglund, Fredrik Sandin, Bengt Simonsson & Leif Stenke. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 37 48 .
Carsten Hirt, Sergio Iannazzo, Silvia Chiroli, Lisa J. McGarry, Philipp le Coutre, Leif Stenke, Torsten Dahlén & Jeffrey H. Lipton. (2019) Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia. Applied Health Economics and Health Policy 17:4, pages 555-567.
Crossref
Marc Delord, Stéphanie Foulon, Jean-Michel Cayuela, Philippe Rousselot & Julia Bonastre. (2018) The rising prevalence of chronic myeloid leukemia in France. Leukemia Research 69, pages 94-99.
Crossref
Paul Cerrato & John Halamka. 2018. Realizing the Promise of Precision Medicine. Realizing the Promise of Precision Medicine 135 148 .
Carolina Pavlovsky & Maria Jose Mela Osorio. (2018) Chronic Myeloid Leukemia: What Is the Best Strategy to Start and Monitor Treatment Outside Academic Centers?. Current Oncology Reports 20:1.
Crossref
Niklas Gunnarsson, Fredrik Sandin, Martin Höglund, Leif Stenke, Magnus Björkholm, Mats Lambe, Ulla Olsson-Strömberg, Johan Richter & Anders Själander. (2016) Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence. European Journal of Haematology 97:4, pages 387-392.
Crossref
Hannah BowerMagnus BjörkholmPaul W. DickmanMartin HöglundPaul C. LambertTherese M.-L. Andersson. (2016) Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. Journal of Clinical Oncology 34:24, pages 2851-2857.
Crossref
Pei-Jung Lin, Aaron N. Winn, Susan K. Parsons, Peter J. Neumann, Elisa S. Weiss & Joshua T. Cohen. (2016) Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia. Medical Care 54:4, pages 380-385.
Crossref
Martin Höglund, Fredrik Sandin & Bengt Simonsson. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 99 110 .
Martin Höglund, Fredrik Sandin & Bengt Simonsson. (2015) Epidemiology of chronic myeloid leukaemia: an update. Annals of Hematology 94:S2, pages 241-247.
Crossref
T. Zander. (2015) Molekular stratifizierte Therapie und patientenrelevante EndpunkteMolecular stratified therapy and patient-relevant endpoints. Forum 30:2, pages 122-126.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.